Alexandria Real Estate Equities Inc
NYSE:ARE

Watchlist Manager
Alexandria Real Estate Equities Inc Logo
Alexandria Real Estate Equities Inc
NYSE:ARE
Watchlist
Price: 95.6 USD -2% Market Closed
Market Cap: 16.5B USD

Alexandria Real Estate Equities Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alexandria Real Estate Equities Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Alexandria Real Estate Equities Inc
NYSE:ARE
Cash from Operating Activities
$1.5B
CAGR 3-Years
14%
CAGR 5-Years
17%
CAGR 10-Years
16%
Boston Properties Inc
NYSE:BXP
Cash from Operating Activities
$1.2B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
6%
Vornado Realty Trust
NYSE:VNO
Cash from Operating Activities
$537.7m
CAGR 3-Years
-11%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
SL Green Realty Corp
NYSE:SLG
Cash from Operating Activities
$129.6m
CAGR 3-Years
-20%
CAGR 5-Years
-19%
CAGR 10-Years
-12%
Cousins Properties Inc
NYSE:CUZ
Cash from Operating Activities
$400.2m
CAGR 3-Years
1%
CAGR 5-Years
6%
CAGR 10-Years
11%
COPT Defense Properties
NYSE:CDP
Cash from Operating Activities
$331m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
5%

Alexandria Real Estate Equities Inc
Glance View

Economic Moat
None
Market Cap
16.5B USD
Industry
Real Estate

In the bustling hub of urban life sciences and technology campuses, Alexandria Real Estate Equities Inc. has carved a niche that integrates real estate acumen with a deep understanding of the life sciences industry. Born in 1994, it emerged as a visionary undertaking, keenly focused on serving the unique needs of life sciences enterprises by providing strategically located and highly sophisticated laboratory and office spaces. Headquartered in Pasadena, California, Alexandria has built a reputation not just as a landlord, but as a partner to a broad spectrum of innovative tenants ranging from biotech startups to global pharmaceutical giants. The company’s properties are primarily located in top innovation clusters like Greater Boston, San Francisco Bay Area, New York City, and San Diego, ensuring close proximity to leading research institutions and talent pools. Alexandria’s business model thrives on a keen strategy of acquiring, developing, and operating properties in these sought-after corridors, where science and technology entrepreneurship flourishes. The company generates revenue through leasing its carefully curated real estate portfolio, with rental income forming the backbone of its financial success. Each property is designed or upgraded to meet the demanding requirements of its tenants, often including state-of-the-art laboratory facilities and amenities that foster collaboration and innovation. This not only enables Alexandria to command premium lease rates but also helps maintain high occupancy levels. The uniqueness of its properties and strategic presence in dynamic markets provide Alexandria with a strong competitive edge, underpinning its growth and establishing its stature in the specialized domain of life sciences real estate investment trusts (REITs).

ARE Intrinsic Value
124.28 USD
Undervaluation 23%
Intrinsic Value
Price

See Also

What is Alexandria Real Estate Equities Inc's Cash from Operating Activities?
Cash from Operating Activities
1.5B USD

Based on the financial report for Dec 31, 2024, Alexandria Real Estate Equities Inc's Cash from Operating Activities amounts to 1.5B USD.

What is Alexandria Real Estate Equities Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
16%

Over the last year, the Cash from Operating Activities growth was -8%. The average annual Cash from Operating Activities growth rates for Alexandria Real Estate Equities Inc have been 14% over the past three years , 17% over the past five years , and 16% over the past ten years .

Back to Top